Data / Form D filings / AgeneBio, Inc.
AgeneBio, Inc.: Form D filings
AgeneBio, Inc., a biotechnology company in Baltimore, MD, filed 12 Form D notices with the SEC between 2009 and 2016. The latest, on July 28, 2016, reports $500,076 sold of a $3 million offering to 5 investors.
Find out what AgeneBio, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1101 E. 33rd STREET, SUITE C310, Baltimore, MD, 21218
- Phone
- (410) 685-3000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1467758
The full lists. Form D filings in Maryland: 608 rows, $30.40, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 28, 2016 | New notice | $3,000,000 | $500,076 | $2,499,924 | 5 | Jul 26, 2016 | sec.gov |
| Feb 6, 2015 | New notice | $900,000 | $400,000 | $500,000 | 1 | Jan 26, 2015 | sec.gov |
| Oct 17, 2014 | New notice | $10,000,000 | $4,113,127 | $5,886,873 | 15 | Oct 3, 2014 | sec.gov |
| Nov 18, 2013 | New notice | $3,300,000 | $1,000,113 | $2,299,887 | 2 | Nov 4, 2013 | sec.gov |
| Jun 4, 2013 | New notice | $4,000,000 | $1,000,000 | $3,000,000 | 6 | May 22, 2013 | sec.gov |
| Sep 25, 2012 | New notice | $975,000 | $450,000 | $525,000 | 6 | Sep 14, 2012 | sec.gov |
| Dec 22, 2011 | Amendment | $5,000,000 | $3,688,610 | $1,311,390 | 27 | Oct 1, 2010 | sec.gov |
| May 19, 2011 | Amendment | $5,000,000 | $1,396,610 | $3,603,390 | 11 | Oct 1, 2010 | sec.gov |
| Jan 7, 2011 | Amendment | $2,000,000 | $846,610 | $1,153,390 | 7 | Oct 1, 2010 | sec.gov |
| Oct 5, 2010 | New notice | $1,000,000 | $110,153 | $889,847 | 1 | Oct 1, 2010 | sec.gov |
| Apr 12, 2010 | New notice | $300,000 | $300,000 | $0 | 1 | Apr 5, 2010 | sec.gov |
| Jul 10, 2009 | New notice | Indefinite | $50,000 | Indefinite | 1 | Jun 30, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| FLOYD W. BLOOM | Director | |
| CHARLES W. CLARVIT | Director | |
| RONALD W. NORDMANN | Director | |
| PATRICK W. LEPORE | Director | |
| MICHELA W. GALLAGHER | Director | |
| GERALD W. MCLAUGHLIN | Executive Officer, Director |
Other biotechnology companies in Maryland that filed recently
- BlueHealer Inc. $1 · Nov 4, 2026
- Accufy Diagnostics, Inc. $2 million · Oct 28, 2026
- OS Therapies Inc $7.2 million · Oct 23, 2026
- Kaigene, Inc. $55 million · Oct 14, 2026
- Templar Nova, Inc. $7 million · Oct 7, 2026
- Monocacy Therapeutics Inc. $25,000 · Oct 7, 2026
- Seraxis Holdings, Inc. $10 million · Sep 24, 2026
- Uvantis Therapeutics, Inc. $100,000 · Sep 23, 2026
- Gliknik Inc $15 million · Sep 17, 2026
- Georgiamune, Inc. $92.7 million · Aug 17, 2026
Every Form D from the week of Jul 25, 2016 · All recent filings in Maryland · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AgeneBio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.